Orion OyjSTU:OFK -0.43%82 EV-to-FCF is 56.74 as of Jun. 29, 2026, which is 108% above its 10-year median of 27.32. GuruFocus rates STU:OFK with a GF Score™ of 82/100 and a GF Value™ of €69.60 (Fairly Valued). The stock has 3 warning signs investors should review. Among 559 Drug Manufacturers companies, Orion Oyj ranks worse than 76.92% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Orion Oyj's Enterprise Value is €9,998 Mil.
Orion Oyj's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €176 Mil. Therefore, Orion Oyj's EV-to-FCF for today is 56.74.
The historical rank and industry rank for Orion Oyj's EV-to-FCF or its related term are showing as below:
STU:OFK'
s EV-to-FCF Range Over the Past 10 Years
Min: -124.66 Med: 27.32 Max: 2556.74
Current: 56.74
During the past 13 years, the highest EV-to-FCF of Orion Oyj was 2556.74. The lowest was -124.66. And the median was 27.32.
STU:OFK's EV-to-FCF is ranked worse than 76.92% of 559
companies
in the Drug Manufacturers industry
Industry Median: 20.02
vs STU:OFK: 56.74
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Orion Oyj's share price for today is €69.85.
Orion Oyj's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.760.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Orion Oyj EV-to-FCF Related Terms
Orion Oyj EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Orion Oyj's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Orion Oyj's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orion Oyj EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Orion Oyj's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Orion Oyj's EV-to-FCF falls into.
Orion Oyj's current Enterprise Value is €9,998 Mil.
Orion Oyj's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €176 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orion Oyj (STU:OFK) has a EV-to-FCF of 56.74 as of Jun. 29, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Orion Oyj and its competitors. This is 108% above median its historical median of 27.32. According to the industry distribution chart, Orion Oyj ranks #430 out of 559 companies in the Drug Manufacturers industry, placing it in the top 76.9%.
Is Orion Oyj's EV-to-FCF too high?
Orion Oyj's current EV-to-FCF of 56.74 is 108% above median its 10-year median of 27.32. The Drug Manufacturers industry median EV-to-FCF is 20.02. Orion Oyj's value of 56.74 is 183.4% above this industry median. Based on the distribution chart, Orion Oyj ranks #430 out of 559 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Orion Oyj has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Orion Oyj's EV-to-FCF compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Orion Oyj ranks #430 out of 559 companies for EV-to-FCF. This places Orion Oyj in the lower half of its industry. The industry median EV-to-FCF is 20.02. Orion Oyj's value of 56.74 is 183.4% above this benchmark. While the company's 10-year median is 27.32 vs. the industry median of 20.02, Orion Oyj has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.02, based on 559 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orion Oyj's current EV-to-FCF of 56.74 is 183.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Orion Oyj and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orion Oyj's current EV-to-FCF is 56.74, which is 108% above median its own 10-year median of 27.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Oyj stock overvalued right now?
Based on GuruFocus' analysis, Orion Oyj (STU:OFK) is currently considered Fairly Valued. The stock's GF Value™ is €69.60, compared to a current price of €69.85 — trading 0.4% above its estimated fair value. The current EV-to-FCF is 56.74, which is 108% above median its 10-year median of 27.32 and 183.4% above the Drug Manufacturers industry median of 20.02. Orion Oyj's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Orion Oyj (STU:OFK), the current EV-to-FCF is 56.74 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orion Oyj (STU:OFK) Overvalued in 2026?
Based on GuruFocus' analysis, Orion Oyj stock appears to be overvalued.
The current stock price of €69.85 is trading 0.4% above its estimated GF Value™ of €69.60.
GuruFocus considers Orion Oyj to be Fairly Valued.
Key valuation signals for STU:OFK:
EV-to-FCF: 56.74 (108% above median its 10-year median of 27.32)
GF Value™: €69.60 vs. price of €69.85 (0.4% above fair value)
Industry Position: 183.4% above the Drug Manufacturers median (#430 of 559)
No single metric tells the full story. See the STU:OFK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
82GF Score
Get the complete analysis for STU:OFK
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OFK has been successfully added to your 
